These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17943658)

  • 21. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.
    Smith DA; Obach RS
    Chem Res Toxicol; 2009 Feb; 22(2):267-79. PubMed ID: 19166333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose response considerations in risk assessment--an overview of recent ILSI activities.
    Holsapple MP; Wallace KB
    Toxicol Lett; 2008 Aug; 180(2):85-92. PubMed ID: 18588961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case studies for statistical analysis of toxicokinetic data.
    Igarashi T; Sekido T
    Regul Toxicol Pharmacol; 1996 Jun; 23(3):193-208. PubMed ID: 8812961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of genetic toxicology information for risk assessment.
    Dearfield KL; Moore MM
    Environ Mol Mutagen; 2005 Dec; 46(4):236-45. PubMed ID: 16258925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative extrapolation of in vitro whole embryo culture embryotoxicity data to developmental toxicity in vivo using the benchmark dose approach.
    Piersma AH; Janer G; Wolterink G; Bessems JG; Hakkert BC; Slob W
    Toxicol Sci; 2008 Jan; 101(1):91-100. PubMed ID: 17905734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing animal subsets in toxicokinetic studies: comparison of non-linear mixed effects modelling with non-compartmental methods.
    Hing JP; Woolfrey SG; Greenslade D; Wright PM
    J Appl Toxicol; 2002; 22(6):437-43. PubMed ID: 12424748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.
    Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA
    Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of ICH--toxicokinetics guidance and its practice--a useful approach for safety drug development].
    Tsuda M; Ohno Y
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):1-14. PubMed ID: 9641814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of preclinical toxicology to findings in early clinical trials.
    Grieshaber CK; Marsoni S
    Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Confounders in interpreting pathology for safety and risk assessment.
    Wolf DC; Mann PC
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):302-8. PubMed ID: 15667835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On-target and off-target-based toxicologic effects.
    Rudmann DG
    Toxicol Pathol; 2013 Feb; 41(2):310-4. PubMed ID: 23085982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation.
    Dorne JL
    Fundam Clin Pharmacol; 2004 Dec; 18(6):609-20. PubMed ID: 15548231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of toxicokinetic studies.
    Smith DA; Humphrey MJ; Charuel C
    Xenobiotica; 1990 Nov; 20(11):1187-99. PubMed ID: 2275214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Framework for gender differences in human and animal toxicology.
    Gochfeld M
    Environ Res; 2007 May; 104(1):4-21. PubMed ID: 16616135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward a new age of cellular pharmacokinetics in drug discovery.
    Zhou F; Zhang J; Li P; Niu F; Wu X; Wang G; Roberts MS
    Drug Metab Rev; 2011 Aug; 43(3):335-45. PubMed ID: 21395404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the pathologist in GLP studies.
    Weber K; Hailey JR; Mann PC; Seaton M; Funk KA
    Toxicol Pathol; 2014 Jan; 42(1):275. PubMed ID: 24436040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.